{"id":810437,"date":"2025-02-07T08:04:29","date_gmt":"2025-02-07T13:04:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/"},"modified":"2025-02-07T08:04:29","modified_gmt":"2025-02-07T13:04:29","slug":"procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/","title":{"rendered":"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN JOSE, Calif., Feb.  07, 2025  (GLOBE NEWSWIRE) &#8212; PROCEPT BioRobotics (Nasdaq: PRCT) (the \u201cCompany\u201d), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2024 after market close on Tuesday, February 25, 2025. The Company\u2019s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.<\/p>\n<p>Investors interested in listening to the conference call may do so by following one of the below links:<\/p>\n<ul type=\"disc\">\n<li>Webcast link for interested listeners:\n<ul type=\"circle\">\n<li><a href=\"https:\/\/nam02.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fq33jvv92&amp;data=05%7C02%7Cm.bacso%40procept-biorobotics.com%7Cea009614ae3d4643aaf808dd29d847d1%7Ca423447f8c564f1cb689ad86a5b3bb69%7C1%7C1%7C638712731109725738%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C4000%7C%7C%7C&amp;sdata=C2333LgjQtAwaPdqgM%2BstvTOCEajikEUNkemXxcpCeU%3D&amp;reserved=0\" rel=\"nofollow\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/q33jvv92<\/a><\/li>\n<\/ul>\n<\/li>\n<li>Dial-in registration for sell-side research analysts:\n<ul type=\"circle\">\n<li><a href=\"https:\/\/nam02.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBI96427501b8ee48bdb09e18cb484392b0&amp;data=05%7C02%7Cm.bacso%40procept-biorobotics.com%7Cea009614ae3d4643aaf808dd29d847d1%7Ca423447f8c564f1cb689ad86a5b3bb69%7C1%7C1%7C638712731109742366%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C4000%7C%7C%7C&amp;sdata=MzUC24DIqp79I3BlyzMenhLYGcTAE6jqxevW40XFQk4%3D&amp;reserved=0\" rel=\"nofollow\" target=\"_blank\">https:\/\/register.vevent.com\/register\/BI96427501b8ee48bdb09e18cb484392b0<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Live audio of the webcast will be available on the \u201cInvestors\u201d section of the Company\u2019s website at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aMk842N3tjf0Ax2seHZQ-l0sy295VsewdNGIr6d6nmQhZETgY1QFvF18YYeLUQ_n-31peGLysv-b5fwQnmZ697A-hyX56puPJ06HxC9bI53MR-E56cwOdORy39u1WdKKtBYJAGxQuTA-nBsNbe6aGBL87RVrdH75is0YcxRSI5Gbz_cIX5_Zu-O_9C8ceaoInZ_561hjuai7FMi-5vELfjQxv0VYG6dj5gmXtZqrm1llq9SScd1tKxS4-0fTROetSqfaAnkHLIjpcBYV7zOHiYLqhH4npu5Pn_5UKYOnJOtYVG2ruKjNlIjnVrkupyNz\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.procept-biorobotics.com<\/a>\u00a0\u00a0<\/p>\n<p>An archived recording will be available on the \u201cInvestors\u201d section of the Company\u2019s website at:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aMk842N3tjf0Ax2seHZQ-l0sy295VsewdNGIr6d6nmSjUJ4EBeMjK0QAWCw--KVvhorT_dmFhOoMB3cqsj52-rDghZ4-R3evhg1KnwrpmJJZfMXtfOO8TPzXmkCAbH5FR3FcN1D4EcLzRavbZ34eHFQuAMtfFLk2j4YoglO-XFGT91NWY9Biv29o_shAmTVbZc973IN76KT4QGeV_4YhmpKHy5hVwORYH6h60tnWc1bTWHSlhH_rs39xp6i98MfblDF71iwZ13FxkcJ4VPb1HVBv-D58s2qBuEBwiQKy440tn2_YPgCAkserSbhbPm-P\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.procept-biorobotics.com<\/a>. The webcasts will be available for replay for at least 90 days after the event.<\/p>\n<p>The Company also announced today that members of management\u00a0will present at the upcoming TD Cowen 45<sup>th<\/sup> Annual Healthcare Conference. Management is scheduled to present on Tuesday, March 4 at 1:10 p.m. Eastern Time. Additionally, members of management will present at the 2025 Leerink Partners Healthcare Conference. Management is scheduled to present on Tuesday, March 11 at 3:00 p.m. Eastern Time.<\/p>\n<p>A live webcast of each event, as well as an archived recording, will be available on the \u201cInvestors\u201d section of the Company\u2019s website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aMk842N3tjf0Ax2seHZQ-l0sy295VsewdNGIr6d6nmQEcdBS3N4GqMclytijvVCcw28RMZCSbvy3m8bhZr6jnwwKdV1wI5zK_TJeMci6Y3bmgKHTaI3pOw030bi7v6h_\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.procept-biorobotics.com<\/a>. The webcasts will be archived and available for replay for at least 90 days after the event.<\/p>\n<p>\n        <strong>About PROCEPT BioRobotics Corporation<\/strong><br \/>\n        <br \/>PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM<sup>\u00ae<\/sup> and HYDROS\u2122 Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Matt Bacso<br \/>VP, Investor Relations and Business Operations<br \/>m.bacso@procept-biorobotics.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjRkYTE4ODAtNWQ2OS00YjAyLWI1NzItZjQ2ODVjMzdlYWQxLTExOTA2Nzk=\/tiny\/PROCEPT-BioRobotics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) &#8212; PROCEPT BioRobotics (Nasdaq: PRCT) (the \u201cCompany\u201d), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2024 after market close on Tuesday, February 25, 2025. The Company\u2019s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by following one of the below links: Webcast link for interested listeners: https:\/\/edge.media-server.com\/mmc\/p\/q33jvv92 Dial-in registration for sell-side research analysts: https:\/\/register.vevent.com\/register\/BI96427501b8ee48bdb09e18cb484392b0 Live audio of the webcast will be available on the \u201cInvestors\u201d section of the Company\u2019s website at:\u00a0https:\/\/ir.procept-biorobotics.com\u00a0\u00a0 An archived recording will be available &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810437","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) &#8212; PROCEPT BioRobotics (Nasdaq: PRCT) (the \u201cCompany\u201d), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2024 after market close on Tuesday, February 25, 2025. The Company\u2019s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by following one of the below links: Webcast link for interested listeners: https:\/\/edge.media-server.com\/mmc\/p\/q33jvv92 Dial-in registration for sell-side research analysts: https:\/\/register.vevent.com\/register\/BI96427501b8ee48bdb09e18cb484392b0 Live audio of the webcast will be available on the \u201cInvestors\u201d section of the Company\u2019s website at:\u00a0https:\/\/ir.procept-biorobotics.com\u00a0\u00a0 An archived recording will be available &hellip; Continue reading &quot;PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T13:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference\",\"datePublished\":\"2025-02-07T13:04:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/\"},\"wordCount\":429,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/\",\"name\":\"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=\",\"datePublished\":\"2025-02-07T13:04:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/","og_locale":"en_US","og_type":"article","og_title":"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - Market Newsdesk","og_description":"SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) &#8212; PROCEPT BioRobotics (Nasdaq: PRCT) (the \u201cCompany\u201d), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2024 after market close on Tuesday, February 25, 2025. The Company\u2019s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by following one of the below links: Webcast link for interested listeners: https:\/\/edge.media-server.com\/mmc\/p\/q33jvv92 Dial-in registration for sell-side research analysts: https:\/\/register.vevent.com\/register\/BI96427501b8ee48bdb09e18cb484392b0 Live audio of the webcast will be available on the \u201cInvestors\u201d section of the Company\u2019s website at:\u00a0https:\/\/ir.procept-biorobotics.com\u00a0\u00a0 An archived recording will be available &hellip; Continue reading \"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-07T13:04:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference","datePublished":"2025-02-07T13:04:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/"},"wordCount":429,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/","name":"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=","datePublished":"2025-02-07T13:04:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NDY0OCM2NzQwMzU0IzIxNzkxMTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/procept-biorobotics-to-report-fourth-quarter-2024-financial-results-on-february-25-2025-and-attend-the-td-cowen-45th-annual-healthcare-conference-and-the-2025-leerink-partners-healthcare-confer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PROCEPT BioRobotics\u00ae to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810437"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810437\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}